Triazolo-pyridazine derivatives as ligands for GABA receptors
US6579875B1 · kind B1 · utility
9Cited by
7References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 28, 2000 |
| Grant date | Jun 17, 2003 |
| Priority date | — |
| Expiry date | Jun 28, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
1,2,4-triazolo[4,3-b]pyridazine derivatives, possessing a fluoro-substituted phenyl ring at the 3-position and a heteroaryl-alkoxy moiety at the 6-position, are selective ligands for GABAA receptors, in particular having high affinity for the &agr;2 and/or &agr;3 subunit thereof, are useful in the treatment of anxiety and convulsions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.